SEC Company Response from CEL SCI CORP (CVM) (CIK 0000725363) (CVM) — Nov 2, 2009
CEL SCI CORP (CVM) (CIK 0000725363)
Date: Nov. 2, 2009 · CIK: 0000725363 · Accession: 0001004878-09-000243
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-161504
Referenced dates: November 2, 2009
Letter
Re: Cel-Sci Corporation Registration Statement on Form S-3 File No. 333-161504
HART & TRINEN, LLP ATTORNEYS AT LAW 1624 Washington Street Denver, CO 80203 William T. Hart, P.C. ________ Email: harttrinen@aol.com Donald T. Trinen Facsimile: (303) 839-5414 (303) 839-0061
November 2, 2009
Rose Zukin Mailstop 4720 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549
This letter provides the Company's responses to the comment received from the staff by letter dated November 2, 2009. The "anti-dilution" provisions of the Series K warrants provide that if the warrant exercise price decreases, the number of shares issuable upon the exercise of the warrants increases. Consequently, if the warrant exercise price was reset to $0.20, and if all remaining Series K warrants were exercised, the proceeds to CEL-SCI from the exercise of warrants would be the same, although CEL-SCI would be required to issue more shares.
The second bullet point of the Risk Factor which is the subject of the staff's comment states that if the warrant exercise price decreases the number of shares issuable upon the exercise of the warrants will increase.
Very Truly Yours,
HART & TRINEN, L.L.P.
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
HART & TRINEN, LLP
ATTORNEYS AT LAW
1624 Washington Street
Denver, CO 80203
William T. Hart, P.C. ________ Email: harttrinen@aol.com
Donald T. Trinen Facsimile: (303) 839-5414
(303) 839-0061
November 2, 2009
Rose Zukin
Mailstop 4720
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Re: Cel-Sci Corporation
Registration Statement on Form S-3
File No. 333-161504
This letter provides the Company's responses to the comment received from
the staff by letter dated November 2, 2009. The "anti-dilution" provisions of
the Series K warrants provide that if the warrant exercise price decreases, the
number of shares issuable upon the exercise of the warrants increases.
Consequently, if the warrant exercise price was reset to $0.20, and if all
remaining Series K warrants were exercised, the proceeds to CEL-SCI from the
exercise of warrants would be the same, although CEL-SCI would be required to
issue more shares.
The second bullet point of the Risk Factor which is the subject of the
staff's comment states that if the warrant exercise price decreases the number
of shares issuable upon the exercise of the warrants will increase.
Very Truly Yours,
HART & TRINEN, L.L.P.
By: /s/ William T. Hart
William T. Hart
WTH:ap
</TEXT>
</DOCUMENT>